Today: 16 April 2026
BAT share price today: British American Tobacco stock edges up as chair term extended and earnings loom
11 February 2026
1 min read

BAT share price today: British American Tobacco stock edges up as chair term extended and earnings loom

London, Feb 11, 2026, 08:15 GMT — Regular session.

  • British American Tobacco climbed roughly 0.6% shortly after the open in London.
  • The board has decided to keep chair Luc Jobin in place until April 2028, while the senior independent director role will shift at the 2026 AGM.
  • Capital Group has cut its stake, leaving investors waiting for Thursday’s annual results to see what’s next.

Shares in British American Tobacco (BATS.L) picked up 0.6% to 4,398 pence as of 0815 GMT. The move follows a board update, with investors looking ahead to the company’s annual results set for Thursday.

This matters for BAT, which faces a crucial results day and fresh governance concerns. Investors are waiting on the figures, sure, but they’re also watching leadership—especially as the company keeps pushing deeper into nicotine alternatives.

British American Tobacco plans to release preliminary 2025 results at 0700 GMT on Feb. 12. A webcast and investor Q&A is set to start at 0930 GMT, featuring Chief Executive Tadeu Marroco and Interim CFO Javed Iqbal.

BAT on Tuesday announced it’s extending Luc Jobin’s stint as chair, locking him in through the company’s AGM in April 2028 while the hunt for his replacement drags on. Senior independent director Holly Keller Koeppel called Jobin “a proven and respected Chair.” For his part, Jobin said, “I look forward to welcoming Karen as Senior Independent Director.” British American Tobacco

The Capital Group Companies reduced its voting stake in BAT to 17.934796%, down from 18.869293%, according to a regulatory filing. The move was detailed in a TR-1 disclosure, the UK’s standard report for investors who hit or fall below specified thresholds.

BAT pressed ahead with its buyback, picking up 149,812 shares on Feb. 9 at a volume-weighted average price of 4,517.1620 pence. The company plans to cancel the shares. Once that happens, it expects to have 2,176,123,491 shares outstanding, excluding those held in treasury.

Even with buybacks underway, it’s straightforward: investors face a risk if earnings disappoint. Boardroom headlines won’t matter much if pricing softens, volumes slip, or the outlook feels less upbeat — any hint of those, and the stock could slide.

Right now, most traders are holding off until Thursday’s release, with management’s comments on the call in focus. There’s interest in the latest on buyback activity, and any word on the chair succession timeline will be scrutinized, along with the top-line numbers.

Stock Market Today

  • Anthropic launches Claude Opus 4.7 amid tense AI rivalry with OpenAI
    April 16, 2026, 4:39 PM EDT. Anthropic released Claude Opus 4.7 as the competition with OpenAI intensifies. OpenAI's chief revenue officer Denise Dresser criticized Anthropic's $30 billion revenue run rate, claiming it is inflated by nearly $8 billion due to accounting methods involving revenue shares with Amazon and Google. Anthropic's rapid growth, tripling since 2025, contrasts with OpenAI's concerns about Anthropic's narrow focus on coding products and insufficient cloud compute capacity. OpenAI stresses the importance of enterprise trust and flexibility, highlighting its expanded $50 billion AWS deal and exclusive cloud platform, OpenAI Frontier. This battle underscores evolving enterprise AI dynamics as players seek broader adoption beyond developer tools.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Morgan Stanley stock slides as AI tax tool spooks wealth managers
Previous Story

Morgan Stanley stock slides as AI tax tool spooks wealth managers

London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up
Next Story

London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up

Go toTop